Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2000

Schlagwörter:	Smoking Cessation Bupropion Cessation Treatment Smoking Cessation Treatment Pharmaceutical Benefit Scheme

Anmerkung:	© Adis International Ltd 2000

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1267(2000), 1 vom: Dez., Seite 22-22
Übergeordnetes Werk:	volume:1267 ; year:2000 ; number:1 ; month:12 ; pages:22-22

Links:	Volltext

DOI / URN:	10.2165/00128413-200012670-00055

Katalog-ID:	SPR036327204

Internformat


LEADER	01000caa a22002652 4500
001	SPR036327204
003	DE-627
005	20230519174642.0
007	cr uuu---uuuuu
008	201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200012670-00055 \|2 doi
035			\|a (DE-627)SPR036327204
035			\|a (SPR)00128413-200012670-00055-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome
264		1	\|c 2000
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2000
650		4	\|a Smoking Cessation \|7 (dpeaa)DE-He213
650		4	\|a Bupropion \|7 (dpeaa)DE-He213
650		4	\|a Cessation Treatment \|7 (dpeaa)DE-He213
650		4	\|a Smoking Cessation Treatment \|7 (dpeaa)DE-He213
650		4	\|a Pharmaceutical Benefit Scheme \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1267(2000), 1 vom: Dez., Seite 22-22 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1267 \|g year:2000 \|g number:1 \|g month:12 \|g pages:22-22
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200012670-00055 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1267 \|j 2000 \|e 1 \|c 12 \|h 22-22

Indexfelder

matchkey_str	article:22306056:2000----::meuaoeurpozbnabeluceiasr
hierarchy_sort_str	2000
publishDate	2000
allfields	10.2165/00128413-200012670-00055 doi (DE-627)SPR036327204 (SPR)00128413-200012670-00055-e DE-627 ger DE-627 rakwb eng Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Smoking Cessation (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Cessation Treatment (dpeaa)DE-He213 Smoking Cessation Treatment (dpeaa)DE-He213 Pharmaceutical Benefit Scheme (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1267(2000), 1 vom: Dez., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1267 year:2000 number:1 month:12 pages:22-22 https://dx.doi.org/10.2165/00128413-200012670-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1267 2000 1 12 22-22
spelling	10.2165/00128413-200012670-00055 doi (DE-627)SPR036327204 (SPR)00128413-200012670-00055-e DE-627 ger DE-627 rakwb eng Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Smoking Cessation (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Cessation Treatment (dpeaa)DE-He213 Smoking Cessation Treatment (dpeaa)DE-He213 Pharmaceutical Benefit Scheme (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1267(2000), 1 vom: Dez., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1267 year:2000 number:1 month:12 pages:22-22 https://dx.doi.org/10.2165/00128413-200012670-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1267 2000 1 12 22-22
allfields_unstemmed	10.2165/00128413-200012670-00055 doi (DE-627)SPR036327204 (SPR)00128413-200012670-00055-e DE-627 ger DE-627 rakwb eng Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Smoking Cessation (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Cessation Treatment (dpeaa)DE-He213 Smoking Cessation Treatment (dpeaa)DE-He213 Pharmaceutical Benefit Scheme (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1267(2000), 1 vom: Dez., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1267 year:2000 number:1 month:12 pages:22-22 https://dx.doi.org/10.2165/00128413-200012670-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1267 2000 1 12 22-22
allfieldsGer	10.2165/00128413-200012670-00055 doi (DE-627)SPR036327204 (SPR)00128413-200012670-00055-e DE-627 ger DE-627 rakwb eng Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Smoking Cessation (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Cessation Treatment (dpeaa)DE-He213 Smoking Cessation Treatment (dpeaa)DE-He213 Pharmaceutical Benefit Scheme (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1267(2000), 1 vom: Dez., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1267 year:2000 number:1 month:12 pages:22-22 https://dx.doi.org/10.2165/00128413-200012670-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1267 2000 1 12 22-22
allfieldsSound	10.2165/00128413-200012670-00055 doi (DE-627)SPR036327204 (SPR)00128413-200012670-00055-e DE-627 ger DE-627 rakwb eng Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Smoking Cessation (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Cessation Treatment (dpeaa)DE-He213 Smoking Cessation Treatment (dpeaa)DE-He213 Pharmaceutical Benefit Scheme (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1267(2000), 1 vom: Dez., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1267 year:2000 number:1 month:12 pages:22-22 https://dx.doi.org/10.2165/00128413-200012670-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1267 2000 1 12 22-22
language	English
source	Enthalten in Inpharma weekly 1267(2000), 1 vom: Dez., Seite 22-22 volume:1267 year:2000 number:1 month:12 pages:22-22
sourceStr	Enthalten in Inpharma weekly 1267(2000), 1 vom: Dez., Seite 22-22 volume:1267 year:2000 number:1 month:12 pages:22-22
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Smoking Cessation Bupropion Cessation Treatment Smoking Cessation Treatment Pharmaceutical Benefit Scheme
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2000-12-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036327204
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036327204</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174642.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012670-00055</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036327204</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012670-00055-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking Cessation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bupropion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cessation Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking Cessation Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Benefit Scheme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1267(2000), 1 vom: Dez., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1267</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012670-00055</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1267</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">12</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome Smoking Cessation (dpeaa)DE-He213 Bupropion (dpeaa)DE-He213 Cessation Treatment (dpeaa)DE-He213 Smoking Cessation Treatment (dpeaa)DE-He213 Pharmaceutical Benefit Scheme (dpeaa)DE-He213
topic	misc Smoking Cessation misc Bupropion misc Cessation Treatment misc Smoking Cessation Treatment misc Pharmaceutical Benefit Scheme
spellingShingle	misc Smoking Cessation misc Bupropion misc Cessation Treatment misc Smoking Cessation Treatment misc Pharmaceutical Benefit Scheme Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome
topic_unstemmed	misc Smoking Cessation misc Bupropion misc Cessation Treatment misc Smoking Cessation Treatment misc Pharmaceutical Benefit Scheme
topic_browse	misc Smoking Cessation misc Bupropion misc Cessation Treatment misc Smoking Cessation Treatment misc Pharmaceutical Benefit Scheme
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome
ctrlnum	(DE-627)SPR036327204 (SPR)00128413-200012670-00055-e
title_full	Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2000
contenttype_str_mv	txt
container_start_page	22
container_volume	1267
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200012670-00055
title_sort	amfebutamone [bupropion; `zyban'] has been launched in australia by glaxo wellcome
title_auth	Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome
abstract	© Adis International Ltd 2000
abstractGer	© Adis International Ltd 2000
abstract_unstemmed	© Adis International Ltd 2000
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome
url	https://dx.doi.org/10.2165/00128413-200012670-00055
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200012670-00055
up_date	2024-07-03T17:01:53.338Z
_version_	1803578101822652416
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036327204</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174642.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012670-00055</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036327204</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012670-00055-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking Cessation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bupropion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cessation Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking Cessation Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Benefit Scheme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1267(2000), 1 vom: Dez., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1267</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012670-00055</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1267</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">12</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
score	7.4008236

Nicht das Richtige dabei?

Schreiben Sie uns!

Amfebutamone [bupropion; `Zyban'] has been launched in Australia by Glaxo Wellcome

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?